Will the ResMed (ASX:RMD) share price continue its massive bull run?

Let's examine further.

| More on:
three excited doctors with hands in the air

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The ResMed Inc (ASX: RMD) share price has had a stellar run this year and is currently nudging record highs.

Since the start of the year, shares in the medical device have soared more than 45%.

In comparison, the broader S&P/ASX200 Index (ASX: XJO) has only managed to gain 13% in 2021.

In the last month, shares in ResMed have continued their massive bull run.

Let's take a look at why investors have continued to push the ResMed share price higher in the past month.

What's been driving the ResMed share price higher?

There have been several catalysts that have helped propel the ResMed share price higher in the last 30 days.

The first catalyst can be traced back to early last month when the medical device company released its full-year results for FY21.

ResMed reported an 8% increase in full year to US$3.2 billion and a 13% jump in non-GAAP net income to US$780.6 million.

The company also upped its quarterly dividend by 8% to US42 cents per share.

However, ResMed did flag that profit margins could be under pressure in the future.

The second catalyst that shot the ResMed share price to record highs was the launch of a new key product.

Last month, the medtech giant launched its next-generation positive airway pressure (PAP) device, AirSense 11, in the United States.

ResMed noted that the product's remote software updates and new tailored features could make it the gold standard for treating sleep apnoea.

Outlook for the ResMed share price

ResMed is a global leader in respiratory medical devices, particularly targeted towards the treatment of sleep apnoea.

In addition, the company also produces invasive and non-invasive ventilators that are used to boost the oxygen intake of patients. 

Shares in ResMed have benefited from the company's strong revenue and earnings growth.

The medtech giant has managed to maintain growth by providing industry-leading products, software and continued investment in research and development.

A recent note from leading broker Morgans indicates that the ResMed share price could continue its massive bull run.

Analysts expect the positive form to continue over the medium term, initiating a $41.34 price target on ResMed's shares.

At the time of writing, the ResMed share price is trading slightly lower for the day at $39.75.

Motley Fool contributor Nikhil Gangaram has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

a man sits back from his laptop computer with both hands behind his head feeling happy to see the Brambles share price moving significantly higher today
Industrials Shares

Up 39% in a year, is there more growth to come for this ASX 200 share?

IML Equity Analyst Josh Freiman shares his views on a major ASX 200 industrial stock.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Catapult, Flight Centre, Nufarm, and Xero shares are storming higher today

These shares are having a strong session on Thursday. But why? Let's find out.

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Healthcare Shares

3 ASX healthcare shares going gangbusters on Thursday

Investors are sending these ASX healthcare stocks soaring today. But why?

Read more »

A young man talks tech on his phone while looking at a laptop. A financial graph is superimposed across the image.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX 200 made it three-for-three losses in a row this Wednesday.

Read more »

A young woman wearing overalls and a yellow t-shirt kicks one leg in the air showing excitement over the latest ASX 200 shares to hit 52-week highs
Share Gainers

Why Brickworks, James Hardie, Megaport, and OFX shares are charging higher today

These shares are having a good time on hump day. But why?

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

ASX investors endured another day of selling this Tuesday.

Read more »

Man pointing at a blue rising share price graph.
Technology Shares

Guess which ASX 300 tech stock is already up 64% in November!

The ASX 300 tech stock is surging higher this month. But why?

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Share Gainers

Why ANZ, Block, Neuren, and Pilbara Minerals shares are pushing higher today

These shares are having a solid session on Tuesday. But why? Let's find out.

Read more »